United States (US) Breast Cancer Core Needle Biopsy Market (2025-2031) | Trends, Growth, Value, Forecast, Segmentation, Competitive Landscape, Outlook, Size & Revenue, Companies, Industry, Share, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Breast Cancer Core Needle Biopsy Market - Industry Life Cycle

3.4 United States (US) Breast Cancer Core Needle Biopsy Market - Porter's Five Forces

3.5 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume Share, By Technology Scope, 2021 & 2031F

3.6 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume Share, By End-use Scope, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence and prevalence of breast cancer in the United States

4.2.2 Technological advancements in core needle biopsy procedures leading to more accurate diagnosis

4.2.3 Growing awareness and emphasis on early detection and screening programs for breast cancer

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for new biopsy technologies

4.3.2 High cost associated with core needle biopsy procedures and related equipment

4.3.3 Limited accessibility to advanced biopsy technologies in certain regions of the United States

6.1 United States (US) Breast Cancer Core Needle Biopsy Market, By Technology Scope

6.1.1 Overview and Analysis

6.1.2 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Technology Scope, 2021- 2031F

6.1.3 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By MRI-Based Breast Biopsy, 2021- 2031F

6.1.4 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Ultrasound-Based Breast Biopsy, 2021- 2031F

6.1.5 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Mammography-Based (Stereotactic) Breast Biopsy, 2021- 2031F

6.1.6 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By CT-Based Breast Biopsy, 2021- 2031F

6.1.7 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Other Image Based Breast Biopsy, 2021- 2031F

6.2 United States (US) Breast Cancer Core Needle Biopsy Market, By End-use Scope

6.2.1 Overview and Analysis

6.2.2 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Biopharmaceutical Companies Hospitals & Diagnostic Laboratories, 2021- 2031F

6.2.3 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021- 2031F

6.2.4 United States (US) Breast Cancer Core Needle Biopsy Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

7.1 United States (US) Breast Cancer Core Needle Biopsy Market Export to Major Countries

7.2 United States (US) Breast Cancer Core Needle Biopsy Market Imports from Major Countries

8.1 Average biopsy success rate

8.2 Adoption rate of advanced core needle biopsy technologies

8.3 Patient satisfaction with biopsy procedures

8.4 Average turnaround time for biopsy results

8.5 Rate of recurrence or need for additional biopsies

9.1 United States (US) Breast Cancer Core Needle Biopsy Market Opportunity Assessment, By Technology Scope, 2021 & 2031F

9.2 United States (US) Breast Cancer Core Needle Biopsy Market Opportunity Assessment, By End-use Scope, 2021 & 2031F

10.1 United States (US) Breast Cancer Core Needle Biopsy Market Revenue Share, By Companies, 2024

10.2 United States (US) Breast Cancer Core Needle Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters